Pravin Dugel - 09 Sep 2025 Form 4 Insider Report for OCULAR THERAPEUTIX, INC (OCUL)

Role: Executive Chairman, President and CEO, Director
Signature: /s/ Todd Anderman, Attorney-in-Fact for Pravin Dugel
Issuer symbol: OCUL
Transactions as of: 09 Sep 2025
Net transactions value: $0
Form type: 4
Filing time: 11 Sep 2025, 16:06:45 UTC
Previous filing: 27 Aug 2025
Next filing: 26 Nov 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Dugel Pravin	Executive Chairman, President and CEO, Director	C/O OCULAR THERAPEUTIX, INC., 15 CROSBY DRIVE, BEDFORD	/s/ Todd Anderman, Attorney-in-Fact for Pravin Dugel	11 Sep 2025	0001700917

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OCUL	Common Stock	Gift	$0	-49,754	-1.5%	$0.000000	3,177,490	09 Sep 2025	Direct	F1
transaction	OCUL	Common Stock	Gift	$0	+49,754		$0.000000	49,754	09 Sep 2025	By spouse	F1
holding	OCUL	Common Stock						250,361	09 Sep 2025	By Pravin Dugel 2024 Irrevocable Trust

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On September 9, 2025, the reporting person transferred 49,754 shares to his spouse for no consideration.

Remarks:

Executive Chairman, President and CEO